PetCaseFinder

Peer-reviewed veterinary case report

Calciprotein particles linked to chronic kidney disease in cats

By Tang, Pak-Kan et al.·Published in Journal of veterinary internal medicine·2026·Department of Comparative Biomedical Sciences, United Kingdom·View original on PubMed

PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →

Original publication title: Calciprotein particles in cats with naturally occurring chronic kidney disease.

Species:
cat

Plain-English summary

A group of 52 cats with chronic kidney disease (CKD) were studied to understand the role of calciprotein particles (CPP) in their condition. These cats were on a special diet to limit phosphate intake. Researchers found that certain hormones in the cats' blood were linked to changes in CPP levels, which can indicate the risk of mineral buildup in soft tissues. The study suggests that monitoring CPP could help veterinarians better assess and manage CKD in cats.

People also search for: cat chronic kidney disease symptoms · cat kidney disease diet · calciprotein particles in cats

Abstract

BACKGROUND: Calciprotein particles (CPP) are nanoparticles that play an important role in the pathogenesis of chronic kidney disease-mineral and bone disorder (CKD-MBD). HYPOTHESIS/OBJECTIVES: Identification of plasma CPP and preliminary exploration of the relationships among CPP concentrations, calcification propensity (T50), and CKD-MBD variables in cats with azotemic CKD. ANIMALS: Cats with azotemic CKD (n = 52) stabilized on a phosphate-restricted diet (PRD). METHODS: Total CPP (T-CPP), low-density CPP (L-CPP), and high-density CPP (H-CPP) were measured in heparinized plasma using a fluorescent bisphosphonate (OsteoSense) after gel filtration. Standardized linear regression models evaluated associations among CPP, T50, and CKD-MBD variables. Generalized estimating equations compared preprandial and postprandial CPP concentrations. Calciprotein particle changes (ΔCPP) between visits were compared between cats with different ionized calcium (iCa) trajectories using independent samples t-test or Mann-Whitney U tests. RESULTS: Fibroblast growth factor-23 (standardized coefficient [sβ], 0.35; P = .04) and parathyroid hormones (sβ, -0.34; P = .042) were significantly associated with preprandial T-CPP concentrations in cats fed a PRD, whereas phosphate was significantly associated with postprandial T-CPP (sβ, 0.72; P = .003) and L-CPP (sβ, 0.75; P = .003) concentrations before dietary phosphate restriction. ΔT-CPP was significantly greater in cats with CKD with uptrend iCa compared to those with downtrend iCa after PRD stabilization (14 105 ± 36 299 AU vs -29 495 ± 49 664 AU; P = .036). CONCLUSIONS AND CLINICAL IMPORTANCE: Calciprotein particle measurement is possible in cats and adds to the assessment of CKD-MBD, particularly the risk of soft tissue mineralization. The trajectory of iCa after PRD might influence CPP concentrations in cats with CKD.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/41806393/